» Articles » PMID: 34782448

Sex-related Differences in Systemic Sclerosis: A Multicenter Cross-sectional Study From the National Registry of the Italian Society for Rheumatology

Abstract

Objective: There is still a great deal to learn about the influence of sex in systemic sclerosis (SSc). In this respect, national registries provide large and homogeneous patient cohorts for analytical studies. We therefore investigated a wide-ranging and well-characterized SSc series with the aim of identifying sex differences in disease expression, with a special focus on demographic, clinical, and serological characteristics.

Methods: A multicenter SSc cohort of 2281 patients, including 247 men, was recruited in the Italian Systemic sclerosis PRogression INvestiGation (SPRING) registry. Demographic data, disease manifestations, serological profile, and internal organ involvement were compared.

Results: The overall female/male ratio was 8.2:1. Female/male ratios for limited cutaneous SSc, diffuse cutaneous SSc, and SSc sine scleroderma subsets were 8.7:1, 4.9:1, and 10.7:1, respectively. A shorter time from onset of Raynaud phenomenon to SSc diagnosis, an increased prevalence of the diffuse cutaneous subset, renal crisis, and digital ulcers were found in males, whereas a significantly higher percentage of sicca syndrome, serum antinuclear antibodies, antiextractable nuclear antigens, anti-La/SSB, and anticentromere protein B was detected in the female group. Males exhibited lower left ventricular ejection fraction, as well as higher prevalence of conduction blocks, arrhythmias, ground glass, and honeycombing. Moreover, forced vital capacity and total lung capacity were medially lower in men than in women. Finally, males were more frequently treated with immunosuppressive drugs.

Conclusion: Our study further supports the presence of several sex-related differences in patients with SSc. These differences were pronounced in the severity of cutaneous, peripheral vascular, and cardiopulmonary involvement for male patients, whereas an increased prevalence of sicca syndrome and a specific autoantibody profile characterized the female sex.

Citing Articles

A scoping review of the epidemiology of systemic sclerosis and its organ manifestations: 2018-2024.

Good S, Lee J, Johnson R, Volkmann E Curr Opin Rheumatol. 2024; 37(2):103-112.

PMID: 39470126 PMC: 11779589. DOI: 10.1097/BOR.0000000000001063.


Untangling the relationship between smoking and systemic sclerosis: an analysis of the EUSTAR cohort.

Ciaffi J, Liem S, Cannegieter S, Ahmed S, Hoekstra E, Wiland P RMD Open. 2024; 10(2).

PMID: 38772679 PMC: 11328649. DOI: 10.1136/rmdopen-2024-004101.


Journey into the Esophageal Complications: Decoding Systemic Sclerosis with Cutting-Edge Endoscopy, Manometry, and Ambulatory pH-Study.

Amin O, Mirza R, Hussein H, Khudhur Z, Awla H, Smail S Int J Gen Med. 2024; 17:1823-1831.

PMID: 38711827 PMC: 11073525. DOI: 10.2147/IJGM.S448421.


Different Kynurenine Pathway Dysregulation in Systemic Sclerosis in Men and Women.

Turska-Kozlowska M, Pedraz-Petrozzi B, Paluszkiewicz P, Parada-Turska J Int J Mol Sci. 2024; 25(7).

PMID: 38612652 PMC: 11011858. DOI: 10.3390/ijms25073842.


Practice pattern for the use of intravenous iloprost for the treatment of peripheral vasculopathy in systemic sclerosis: A case-control study from the Italian national multicenter "SPRING" (Systemic Sclerosis Progression InvestiGation) Registry.

Riccieri V, Pellegrino G, Cipolletta E, Giuggioli D, Bajocchi G, Bellando-Randone S J Scleroderma Relat Disord. 2024; 9(1):38-49.

PMID: 38333531 PMC: 10848931. DOI: 10.1177/23971983231209809.